HealthCor Management

HealthCor Management as of Dec. 31, 2021

Portfolio Holdings for HealthCor Management

HealthCor Management holds 67 positions in its portfolio as reported in the December 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Medtronic SHS Call Option (MDT) 10.2 $187M 1.8M 103.45
Bristol Myers Squibb (BMY) 6.1 $113M 1.8M 62.35
Biogen Idec (BIIB) 5.9 $109M 453k 239.92
Horizon Therapeutics Pub L SHS 4.9 $90M 832k 107.76
Envista Hldgs Corp (NVST) 4.0 $74M 1.6M 45.06
Natera (NTRA) 3.8 $70M 753k 93.39
AmerisourceBergen (COR) 3.8 $69M 521k 132.89
Tenet Healthcare Corp Com New (THC) 3.5 $64M 782k 81.69
Centene Corporation (CNC) 3.4 $62M 750k 82.40
Pet Acquisition LLC -Class A (WOOF) 2.9 $54M 2.7M 19.79
Boston Scientific Corporation (BSX) 2.9 $54M 1.3M 42.48
Danaher Corporation (DHR) 2.7 $50M 151k 329.01
Johnson & Johnson (JNJ) 2.6 $48M 280k 171.07
Anthem (ELV) 2.6 $47M 102k 463.54
Jazz Pharmaceuticals Shs Usd (JAZZ) 2.4 $45M 349k 127.40
Stryker Corporation (SYK) 2.3 $43M 159k 267.42
Livanova SHS (LIVN) 2.0 $38M 431k 87.43
Universal Hlth Svcs CL B (UHS) 2.0 $37M 286k 129.66
Select Sector Spdr Tr Sbi Healthcare (XLV) 1.9 $36M 254k 140.89
Cooper Cos Com New 1.8 $34M 80k 418.94
Nevro (NVRO) 1.8 $33M 409k 81.07
BioCryst Pharmaceuticals (BCRX) 1.8 $33M 2.4M 13.85
Neurocrine Biosciences (NBIX) 1.7 $31M 366k 85.17
Abbott Laboratories (ABT) 1.6 $29M 203k 140.74
Humana (HUM) 1.4 $25M 55k 463.85
Syndax Pharmaceuticals (SNDX) 1.4 $25M 1.2M 21.89
Revance Therapeutics 1.3 $24M 1.4M 16.32
Hca Holdings (HCA) 1.2 $22M 84k 256.92
Longview Acquisition Corp Ii Com Cl A 1.1 $21M 2.1M 9.84
Pfizer (PFE) 1.1 $20M 339k 59.05
Avantor (AVTR) 1.0 $18M 428k 42.14
Regeneron Pharmaceuticals (REGN) 1.0 $18M 28k 631.53
Abbvie (ABBV) 0.9 $17M 125k 135.40
McKesson Corporation (MCK) 0.9 $16M 64k 248.57
UnitedHealth (UNH) 0.8 $15M 29k 502.14
Cano Health Com Cl A 0.8 $14M 1.6M 8.91
BioMarin Pharmaceutical (BMRN) 0.8 $14M 159k 88.35
Amgen (AMGN) 0.8 $14M 63k 224.96
Research Alliance Corp Ii Com Cl A 0.7 $13M 1.3M 9.72
Henry Schein (HSIC) 0.5 $9.9M 128k 77.53
ImmunoGen 0.5 $9.7M 1.3M 7.42
Affimed Therapeutics B V 0.5 $9.5M 1.7M 5.52
Chemocentryx 0.5 $8.8M 241k 36.41
Incyte Corporation (INCY) 0.4 $7.9M 108k 73.40
Rapt Therapeutics 0.4 $6.7M 181k 36.73
Quanterix Ord (QTRX) 0.3 $5.7M 134k 42.40
Seagen 0.3 $5.2M 34k 154.59
Hyperfine Com Cl A (HYPR) 0.3 $5.0M 692k 7.25
Veracyte (VCYT) 0.3 $4.9M 120k 41.20
Arya Sciences Acquisitn Corp Class A Ord Shs 0.3 $4.9M 500k 9.70
Cytokinetics Com New (CYTK) 0.2 $4.3M 94k 45.58
Halozyme Therapeutics (HALO) 0.2 $4.2M 105k 40.21
Stereotaxis Com New (STXS) 0.2 $4.1M 657k 6.20
Inspire Med Sys (INSP) 0.2 $4.0M 18k 230.07
Ikena Oncology (IKNA) 0.2 $3.6M 288k 12.54
Merus N V (MRUS) 0.2 $3.6M 112k 31.80
Leap Therapeutics 0.2 $3.5M 1.1M 3.24
Axonics Modulation Technolog (AXNX) 0.2 $3.3M 59k 56.01
Pyxis Oncology Common Stock (PYXS) 0.1 $2.7M 245k 10.97
Orion Acquisition Corp Com Cl A 0.1 $2.0M 200k 9.78
Dice Therapeutics 0.1 $1.9M 75k 25.32
Longview Acquisition Corp Ii *w Exp 99/99/999 0.0 $363k 427k 0.85
Bridgebio Pharma Call Option (BBIO) 0.0 $167k 10k 16.70
Eqrx *w Exp 12/17/202 0.0 $107k 100k 1.07
Orion Acquisition Corp *w Exp 02/19/202 0.0 $89k 137k 0.65
Medicus Sciences Acquisition *w Exp 02/12/202 0.0 $60k 83k 0.73
Eucrates Biomedical Acqu Cor *w Exp 10/23/202 0.0 $45k 78k 0.58